[1]
B. B. Samura, “Interactions between galectin-3 and cardiovascular risk in patients with chronic lymphocytic leukemia in remission: results of 3-year prospective study”, Current issues in pharmacy and medicine: science and practice, no. 3, Oct. 2018.